Why Shattuck Labs Stock Soared in December
Shattuck Labs(US:STTK) The Motley Fool·2026-01-06 03:30Buttressed by a significant amount of fresh capital, the company is showing progress in the early development of its top investigational drug.A recommendation upgrade from an analyst at the beginning of December set the tone for Shattuck Labs (STTK +4.85%) stock in 2025's final month. The clinical-stage biotech's share price rose by almost 74% as a result.Good for what ails you The person responsible for that influential move was H.C. Wainwright's Joseph Pantginis, who on Dec. 1 shifted his recommendation o ...